ATE489109T1 - Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin - Google Patents

Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin

Info

Publication number: ATE489109T1
Authority: AT; Austria
Prior art keywords: imatinib; midostaurin; treatment; gastrointestinal stroma; tumors
Prior art date: 2003-09-19

Application number

AT04765359T

Other languages

English (en)

Inventor

Sasa Dimitrijevic

Jonathan Fletcher

Sandra SILBERMAN

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-19

Filing date

2004-09-17

Publication date

2010-12-15

2004-09-17 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2010-12-15 Application granted granted Critical

2010-12-15 Publication of ATE489109T1 publication Critical patent/ATE489109T1/de

Links

239000005517 L01XE01 - Imatinib Substances 0.000 title abstract 3
KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 title abstract 3
229960002411 imatinib Drugs 0.000 title abstract 3
BMGQWWVMWDBQGC-IIFHNQTCSA-N midostaurin Chemical compound CN([C@H]1[C@H]([C@]2(C)O[C@@H](N3C4=CC=CC=C4C4=C5C(=O)NCC5=C5C6=CC=CC=C6N2C5=C43)C1)OC)C(=O)C1=CC=CC=C1 BMGQWWVMWDBQGC-IIFHNQTCSA-N 0.000 title abstract 2
229950010895 midostaurin Drugs 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 title 1
230000002496 gastric effect Effects 0.000 title 1
206010051066 Gastrointestinal stromal tumour Diseases 0.000 abstract 2
201000011243 gastrointestinal stromal tumor Diseases 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT04765359T 2003-09-19 2004-09-17 Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin ATE489109T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US50424503P	2003-09-19	2003-09-19
PCT/EP2004/010467 WO2005027971A1 (en)	2003-09-19	2004-09-17	Treatment of gastrointestinal stromal tumors with imatinib and midostaurin

Publications (1)

Publication Number	Publication Date
ATE489109T1 true ATE489109T1 (de)	2010-12-15

Family

ID=34375467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04765359T ATE489109T1 (de)	2003-09-19	2004-09-17	Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin

Country Status (11)

Country	Link
US (1)	US20080096864A1 (de)
EP (1)	EP1667719B1 (de)
JP (1)	JP2007505859A (de)
CN (1)	CN100467064C (de)
AT (1)	ATE489109T1 (de)
AU (1)	AU2004273605B2 (de)
BR (1)	BRPI0414527A (de)
CA (1)	CA2538523A1 (de)
DE (1)	DE602004030265D1 (de)
MX (1)	MXPA06003056A (de)
WO (1)	WO2005027971A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1686997E (pt) *	2003-11-18	2009-07-17	Novartis Ag	Inibidores da forma mutante de kit
RU2410098C2 (ru) *	2004-08-31	2011-01-27	Новартис Аг	Применение мидостаурина для лечения желудочно-кишечных стромальных опухолей
CN103638028A (zh) *	2005-05-02	2014-03-19	诺瓦提斯公司	嘧啶基氨基苯甲酰胺衍生物用于治疗全身性肥大细胞增多症的应用
BRPI0613863A2 (pt)	2005-07-20	2011-02-15	Peter Valent	composições para tratamento de mastocitose sistêmica
WO2007054579A1 (en) *	2005-11-14	2007-05-18	Universität Zürich	Staurosporine derivatives for use in alveolar rhabdomyosarcoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO4940418A1 (es) *	1997-07-18	2000-07-24	Novartis Ag	Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
ITMI992711A1 (it) *	1999-12-27	2001-06-27	Novartis Ag	Composti organici
SK287335B6 (sk) *	2000-10-27	2010-07-07	Novartis Ag	Použitie 4-{(4-metylpiperazin-1-ylmetyl)-N-[4-metyl-3-(4-pyrid-3- yl)pyrimidin-2-ylamino]fenyl}-benzamidu na prípravu farmaceutických kompozícií na liečenie gastrointestinálnych strómových tumorov
AU2003214079B2 (en) *	2002-02-28	2007-05-31	Novartis Ag	N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
ES2303585T3 (es) *	2002-04-10	2008-08-16	Virginia Commonwealth University	Combinacion de glivec(sti571) con un inhibidor de quinasa dependiente de ciclina, especialmente flavopiridol en el tratamiento de cancer.

2004
- 2004-09-17 CN CNB2004800270630A patent/CN100467064C/zh not_active Expired - Fee Related
- 2004-09-17 DE DE602004030265T patent/DE602004030265D1/de not_active Expired - Lifetime
- 2004-09-17 US US10/572,259 patent/US20080096864A1/en not_active Abandoned
- 2004-09-17 AT AT04765359T patent/ATE489109T1/de not_active IP Right Cessation
- 2004-09-17 MX MXPA06003056A patent/MXPA06003056A/es not_active Application Discontinuation
- 2004-09-17 JP JP2006526596A patent/JP2007505859A/ja active Pending
- 2004-09-17 AU AU2004273605A patent/AU2004273605B2/en not_active Ceased
- 2004-09-17 CA CA002538523A patent/CA2538523A1/en not_active Abandoned
- 2004-09-17 BR BRPI0414527-5A patent/BRPI0414527A/pt not_active IP Right Cessation
- 2004-09-17 WO PCT/EP2004/010467 patent/WO2005027971A1/en not_active Ceased
- 2004-09-17 EP EP04765359A patent/EP1667719B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2004273605A1 (en)	2005-03-31
CA2538523A1 (en)	2005-03-31
EP1667719A1 (de)	2006-06-14
EP1667719B1 (de)	2010-11-24
CN100467064C (zh)	2009-03-11
AU2004273605B2 (en)	2008-07-31
JP2007505859A (ja)	2007-03-15
DE602004030265D1 (de)	2011-01-05
BRPI0414527A (pt)	2006-11-07
CN1852738A (zh)	2006-10-25
US20080096864A1 (en)	2008-04-24
WO2005027971A1 (en)	2005-03-31
MXPA06003056A (es)	2006-05-31

Similar Documents

Publication	Publication Date	Title
HRP20090281T1 (hr)	2009-06-30	1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
GEP20053600B (en)	2005-08-10	3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
EA201000050A1 (ru)	2010-08-30	Замещенные бициклолактамные соединения
TW200635923A (en)	2006-10-16	Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
TW200502230A (en)	2005-01-16	Dual nk1/nk3 derivatives
ATE384058T1 (de)	2008-02-15	Thiazolderivate
WO2006005609A3 (de)	2006-03-16	Substituierte oxindol-derivate und diese enthaltende arzneimittel
ATE389395T1 (de)	2008-04-15	Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
MXPA06009475A (es)	2007-05-15	Derivados de quinazolina y usos terapeuticos de los mismos.
DE60312736D1 (de)	2007-05-03	1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE534391T1 (de)	2011-12-15	3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
NO20044475L (no)	2004-11-10	2-(2,6-diklorfenyl)-diarulimidazoler
PE20030061A1 (es)	2003-02-08	1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
WO2006072458A3 (de)	2006-10-05	Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
MX2009004898A (es)	2009-05-19	Derivados de indol y de benzofurano-2-carboxamida.
ATE311389T1 (de)	2005-12-15	Wirkstoffvorläufer von imidazopyridin-derivaten
TW200628466A (en)	2006-08-16	Quinazoline derivatives
ATE466842T1 (de)	2010-05-15	3-substituierte pyridinderivate als h3- antagonisten
MX2007007027A (es)	2007-07-04	Derivados piperazinilpiridina como agentes anti-obesidad.
EA200701181A1 (ru)	2008-02-28	Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
ATE449776T1 (de)	2009-12-15	Pyrroloä2,3-cüpyridinderivate
SE0002729D0 (sv)	2000-07-20	Novel compound form
DE602004030265D1 (de)	2011-01-05	Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin
DE602006005640D1 (de)	2009-04-23	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
NO20070878L (no)	2007-02-16	Dimere piperidinderivater

Legal Events

Date	Code	Title	Description
2011-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties